Best chemotherapy adjuvant for Liver Cancer. | 1+1> 487%
Hepatocellular Carcinoma / HCC / Hepatoma / Hepatoblastma / Liver Cancer
Effectively improve chemotherapy effect, treatment, immunity.
Reduce side effects and recurrence.
Combination Therapy | Overview / Relationship / Abstract/Role / Principle / Action / Mechanism / Function / Work.
Abstract / Summary / Overview of Liver Cancer. (Hepatocellular Carcinoma, HCC, Hepatoma, Hepatoblastma)
Abstract / Summary / Overview of Apoptosis.
Role, Principle, Action, Mechanism, Function, Work of Solamargine.
1. Anticancer activity evaluation of the solanum glycoalkaloid Solamargine. Triggering apoptosis in human hepatoma cells.
2. Bioactive glycoalkaloides isolated from Solanum melongena fruit peels with potential anticancer properties against hepatocellular carcinoma cells.
3. Induction of apoptosis in human hepatoma SMMC-7721 cells by Solamargine from Solanum nigrum L.
4. Solamargine triggers hepatoma cell death through apoptosis.
5. Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity.
6. Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition.
7. Integrated Treatment of Aqueous Extract of Solanum nigrum-Potentiated Cisplatin- and Doxorubicin-Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells.
Abstract / Summary / Overview of Liver Cancer.
Hepatocellular Carcinoma / HCC / Hepatoma / Hepatoblastma
Liver cancer is one of the most common malignant diseases worldwide.
Chronic inflammatory liver disease due to high-fat diet, alcohol consumption, and chronic infection such as hepatitis virus B and C are the most common leading causes of Hepatocellular carcinoma (HCC).
Hepatocellular carcinoma (HCC) is a common type of malignant liver tumor with >600,000 cases diagnosed per year in word.
Hepatocellular carcinoma (HCC) is progressively increasing tumor with lack of accurate prognosis and inadequate systemic treatment approaches.
Almost 80% of patients die within one year of Hepatocellular carcinoma (HCC) diagnosis.
The five-year survival rate of this disease is <9% and the number of mortalities associated with hepatocellular carcinoma (HCC) is >500,000 patients per year.
A major challenge in treating Hepatocellular carcinoma (HCC) is the poor prognosis for advanced and recurrent cases.
Although chemotherapy is the main approach used to treat advanced and recurrent HCC cases, its clinical performance is largely limited by various factors such as a relatively low response rate, drug resistance, and various adverse effects that substantially impact the quality of life (QOL) of Hepatocellular carcinoma (HCC) patients.
Although recent advances in the understanding of the biological characteristics of this illness and multidisciplinary therapeutic approaches, such as individuated chemotherapy, targeted therapies, immune approaches, and improved supportive care, the outcome remains dismal for patients with advanced disease.
One approach to overcome this problem is the development of new agents that can be used in combination with existing chemotherapeutics to yield better results than chemotherapeutics alone.
Therefore, searching for more effective alternative treatment strategies in order to strengthen the therapeutic efficacy with negligible side effects is urgently needed.
Accumulating evidence suggests that many natural products, including extracts and isolated chemicals, have the potential to interact with multiple targets in the signaling pathways that regulate cancer progression.
Natural phytochemicals derived from medicinal plants have gained significant recognition in the control of carcinogenesis and are considered as a novel approach in the prevention and treatment of cancer.
A large number of investigators have now reported that Solamargine induces cell cycle arrest and apoptosis in a wide variety of cancer cells, such as basal cell carcinoma, squamous cell carcinoma, melanoma, colorectal cancer, bladder cancer, oral epidermoid carcinoma, myelogenous leukemia, prostate cancer, breast cancer, lung cancer, endometrial cancer, pancreatic cancer, gastric carcinoma, renal cancer, uterine cancer, mesothelioma, glioblastoma, osteosarcoma, Liver Cancer (Hepatocellular Carcinoma, HCC, Hepatoma, Hepatoblastma).
Apoptosis or programmed cell death plays a significant role in the growth regulation of normal and neoplastic tissues, since it balances cell proliferation.
Apoptosis usually occurs in a well-designed sequence of morphological events mediated by intrinsic and extrinsic pathways and has been demonstrated to activate the programmed cell death pathway to exert anticancer functions.
Abstract / Summary / Overview of Apoptosis.
•Programmed cell death.
•Apoptosis is a form of programmed cell death, or “cellular suicide.”
•Apoptosis is different from necrosis, in which cells die due to injury.
•Apoptosis removes cells during development, eliminates potentially cancerous and virus-infected cells, and maintains balance in the body.
Why do cells undergo apoptosis?
Basically, apoptosis is a general and convenient way to remove cells that should no longer be part of the organism.
Some cells are abnormal and could hurt the rest of the organism if they survive, such as cells with viral infections or DNA damage.
Apoptosis is part of development.
In many organisms, programmed cell death is a normal part of development.
The relationship between cancer cells and apoptosis.
Apoptosis can eliminate infected or cancerous cells.
When a cell’s DNA is damaged, it will typically detect the damage and try to repair it.
If the damage is beyond repair, the cell will normally send itself into apoptosis, ensuring that it will not pass on its damaged DNA.
When cells have DNA damage but fail to undergo apoptosis, they may be on the road to cancer.
However, “successful” cancer cells successfully evade the process of apoptosis.
This allows them to divide out of control and accumulate mutations (changes in their DNA).
Apoptosis is key to immune function.
Apoptosis also plays an essential role in the development and maintenance of a healthy immune system.
Apoptosis or programmed cell death plays a significant role in the growth regulation of normal and neoplastic tissues, since it balances cell proliferation.
Cells undergoing apoptosis usually present cell shrinkage, chromatin condensation, nuclear fragmentation and apoptotic bodies.
Apoptosis usually occurs in a well-designed sequence of morphological events mediated by intrinsic and extrinsic pathways, and has been demonstrated to activate the programmed cell death pathway to exert anticancer functions.
Numerous antitumor drugs are known to trigger cell death by inducing apoptosis.
Where are the weaknesses and symptoms of cancer cells?
The symptoms of cancer cells are in the nucleus.
The nucleus controls the outer cytoplasm, cell composition, cell viability, etc.
DNA mutations also mutate in the nucleus.
Therefore, to treat cancer cells, we must first enter the nucleus.
Let the “regulatory cell gene” mechanism enter the nucleus to regulate
Are cancer cells aggressive?
After the action of Solamargine, the aggressiveness of cancer cells is alleviated.
So after using Solamargine, many patients feel that I am half better.
Although the tumor does not disappear quickly, patients feel that the degree of aggressiveness is reduced.
Role, Principle, Action, Mechanism, Function, Work of Solamargine.
Solamargine major function mechanism, role, principle, action, function, work:
When Solamargine enter,
Solamargine activates receptors that are turned off by cancer cells, allowing cancer cells to modulate again.
Solamargine modulates the anti-modulates genes of cancer cells, making cancer cells less resistant.
Reduced drug resistance (Reduce resistance).
When cancer cells are less resistant to drugs, chemotherapy becomes more effective.
Solamargine modulates the mutated genes in cancer cells and then initiates cancer cell apoptosis to achieve anti-cancer effects.
More specifically, it was shown the Solamargine, in particular, induced apoptosis (target) in cancer cells but not normal cells.
Solamargine combined with which chemotherapy drugs are more effective in treating cancer cells?
A: Cisplatin (CDDP) , Cranberry, Methotrexate, 5-Fu.
Best chemotherapy adjuvant for Liver Cancer. | 1+1> 487%
Effectively improve chemotherapy effect, treatment, immunity.
Reduce side effects and recurrence.
Combination Therapy | Overview / Relationship / Abstract / Role / Principle / Action / Mechanism / Function / Work.
Hepatocellular Carcinoma / HCC / Hepatoma / Hepatoblastma
Solamargine vs Cancer
ANTI-CANCER
Patent protection in 32 nations.
A comparison study showing Solamargine vs. other therapeutic drugs with respect to lung cancer cells.
Solamargine, the typical metabolites of solanum lycocarpum fruit glycoalkaloid extract from traditional herbal medicine, demonstrated not only anti-viral, anti-inflammatory but also antiproliferative activity against the multiple types of human cancers including Liver.
Solamargine, isolated from Solanum incanum herb, displayed a superior cytotoxicity in four human lung cancer cell lines.
Solamargine not only inhibits cell growth of lung cancer (SCLC, NSCLC), Liver Cancer (Hepatocellular Carcinoma, HCC, Hepatoma, Hepatoblastma), Melanoma, and Cholangiocarcinoma but also enhances the cytotoxicity of chemotherapy agents such as cisplatin, doxorubicin, and docetaxel.
Arrows indicate individuals with apoptosis.
The picture shows the death of cancer cells.
The black and black parts are cancer cell nuclei.
Even if the nucleus ruptures, the cancer cells will die.
The figure shows that cancer cells can cause death.
The figure shows that cancer cells can cause death.
The figure shows that the death of lung cancer cells is relatively slow, and it will not be obvious until eight hours later.
The figure shows that the death of Liver Cancer cells is very obvious, even more obvious in eight hours.
The graph shows that Breast Cancer cells die faster. It was obvious from the beginning that Breast Cancer is easy to treat, and patients with Breast Cancer need not worry.
1.Anticancer activity evaluation of the solanum glycoalkaloid Solamargine. Triggering apoptosis in human hepatoma cells.
2.Bioactive glycoalkaloides isolated from Solanum melongena fruit peels with potential anticancer properties against hepatocellular carcinoma cells.
3.Induction of apoptosis in human hepatoma SMMC-7721 cells by Solamargine from Solanum nigrum L.
4.Solamargine triggers hepatoma cell death through apoptosis.
5. Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity.
6. Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition.
7. Integrated Treatment of Aqueous Extract of Solanum nigrum-Potentiated Cisplatin- and Doxorubicin-Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells.
Results :
1.The current study confirms the antiproliferative anticancer activity of Solamargine isolated from the methanolic extract of the fruit peels of Solanum melongena against liver cancer cells (Huh7, HepG2, Hep3B, SMMC7721) lines of different susceptibility.
2. The suppressive effect of Solamargine on liver cancer cell viability and proliferation was determined by MTT and colony formation assays.
3. Solamargine may inhibit the migration and invasion viability of liver cancer cells by blocking EMT.
4.Proliferation of hepatoma cells is inhibited by Solamargine.
5. Clonogenicity of hepatoma cells is decreased by Solamargine.
6. Solamargine potentiated cisplatin and doxorubicin induced cytotoxicity in liver cancer cells but had no effect on normal human pulmonary fibroblasts (WI-38 cells).
7. Integrated treatment of Solamargine with cisplatin and doxorubicin may substantially reduce the required dose of cisplatin and doxorubicin required to achieve the same tumor-suppression efficiency, thereby improving the quality of life (QOL) of Hepatocellular carcinoma (HCC) patients during chemotherapy.
8. Solamargine cotreatment potentiated cisplatin- and doxorubicin-induced cytotoxicity in human HCC cells.
9. Solamargine can be used in novel integrated chemotherapy with cisplatin and doxorubicin to improve tumor-suppression efficiency in HCC treatment.
Combination Therapy | Research results for lung cancer cells.
A. Cisplatin (100μM), 16% of cancer cell apoptosis.
B. Alone SM (4.8μM), 28% of cancer cell apoptosis.
C. SM (4.80μM) + Cisplatin (40pμM), 66% of cancer cells apoptosis.
D. SM (4.80μM) + Cisplatin (100μM), 78% of cancer cell apoptosis.
Solamargine has a clearing effect better than Cisplatin.
The combined treatment of Solamargine and Cisplatin significantly increased the apoptosis of lung cancer cells.
SM (4.8μM) + Cisplatin (40μM), increased from 16% to 66% (up to 4.125 times).
SM (4.8μM) + Cisplatin (100μM), increased from 16% to 78% (up to 4.875 times).
Reorganized from: BBRC. Action of Solamargine on TNFs and drug-resistant human lung cancer cells 2004.
All excerpted from: https://www.ncbi.nlm.nih.gov/
The best solution for cancer cells.
AASLD guideline
adenocarcinoma in liver
advanced hcc definition
advanced hepatocellular carcinoma
alternative treatment for hepatocellular carcinoma
angiosarcoma
apasl guidelines
background of liver cancer
BCLC staging
bclc staging
benign hepatoma
best liver cancer doctor in new york
bile duct cancer johns hopkins
cabometyx (cabozantinib-s-malate)
can cancer be cured with chemotherapy
can hcc be cured
can liver cancer be cured with chemotherapy?
can liver cancer be genetic
cancer in the lining of the liver
cancer secondary sites
canvas non hcc student login
carcinomas
chemotherapy advisor colon cancer
chemotherapy for liver cancer stage 4
chemotherapy for secondary liver cancer
chemotherapy liver cancer life expectancy
cisplatin
cisplatin for pancreatic cancer
cisplatin hcc
classification of hepatoblastoma
cleveland clinic liver cancer
colon cancer hcc
Colorectal cancer risk factor
complications of hepatocellular carcinoma
CT liver 3 phase
dealing with liver cancer
diffuse hepatocellular disease
does liver cancer show up in blood tests
dose of sorafenib in hcc
doxorubicin hepatocellular carcinoma
drugs for hepatocellular carcinoma
end of life care for liver cancer patients
facts about hepatocellular carcinoma
frequently asked questions about liver cancer
gateway community college ct
hcc guidelines
hcc instructure
hcc liver
hcc login
hcc online
hcc online services
HCC paraneoplastic syndrome
hcc rupture
HCC rupture
hcc self service
hcc sign up
hcc stafford
HCC stage
hcc staging uptodate
HCC symptoms
HCC TINY note
hcc treatment
hcc treatment algorithm
hcc treatment guidelines
hcc treatment landscape
hcc treatment ppt
hcc treatment sorafenib
HCC UpToDate
hcc west loop
hcc's login
hepatic artery infusion
hepatic artery infusion (hai)
Hepatic cancer
hepatoblastoma benign or malignant
hepatoblastoma blog
hepatoblastoma causes
hepatoblastoma clinical presentation
hepatoblastoma diagnosis
hepatoblastoma genetics
hepatoblastoma in adults
hepatoblastoma in siblings
hepatoblastoma incidence
hepatoblastoma liver transplant
hepatoblastoma pathology
hepatoblastoma pathology outlines
hepatoblastoma ppt
hepatoblastoma prognosis
hepatoblastoma radiology
hepatoblastoma recurrence
hepatoblastoma relapse
hepatoblastoma ribbon color
hepatoblastoma spread to lungs
hepatoblastoma stages
hepatoblastoma staging
hepatoblastoma survival rate
hepatoblastoma survival stories
hepatoblastoma symptoms
hepatoblastoma symptoms toddler
hepatoblastoma treatment
hepatoblastoma treatment guidelines
hepatoblastoma treatment in india
hepatoblastoma treatment protocol
hepatoblastoma ultrasound
hepatoblastoma uptodate
hepatoblastoma usmle
hepatoblastoma vs hepatocellular carcinoma
hepatoblastoma, thrombocytosis
hepatoblastomapdf
hepatocellular cancer treatments
hepatocellular carcinoma
Hepatocellular carcinoma - uptodate
Hepatocellular carcinoma 2019
hepatocellular carcinoma blood test
hepatocellular carcinoma case presentation
hepatocellular carcinoma causes
hepatocellular carcinoma complications
hepatocellular carcinoma detection
hepatocellular carcinoma diagnosis criteria
Hepatocellular carcinoma ICD 10
Hepatocellular carcinoma ICD 9
Hepatocellular carcinoma ICD-10
hepatocellular carcinoma icd-10
hepatocellular carcinoma immunotherapy
Hepatocellular carcinoma introduction
Hepatocellular carcinoma nejm
Hepatocellular carcinoma Pathology
hepatocellular carcinoma pathophysiology
hepatocellular carcinoma powerpoint
hepatocellular carcinoma ppt
hepatocellular carcinoma presentation
hepatocellular carcinoma prognosis
Hepatocellular carcinoma review
hepatocellular carcinoma review
hepatocellular carcinoma risk factors
hepatocellular carcinoma staging
hepatocellular carcinoma survival rate
Hepatocellular carcinoma symptoms
hepatocellular carcinoma treatment guidelines
hepatocellular carcinoma treatment review
hepatocellular carcinoma treatment uptodate
Hepatocellular carcinoma uptodate
hepatoma benign
hepatoma causes
hepatoma in dogs
hepatoma medical term
hepatoma ppt
hepatoma prognosis
hepatoma quizlet
hepatoma radiology
hepatoma symptoms
hepatoma treatment
hepatoma ultrasound
hepatoma vs hepatocellular carcinoma
hepatomas animal
houston community college programs
how fast does chemo work to shrink tumors
how long can you take sorafenib
how to detect liver cancer early
how to protect liver during chemotherapy
howard community college email
howard community college help desk
howard community college library
howard community college login
Hypodense lesion
immunotherapy for liver cancer
infantile choriocarcinoma of the liver
inoperable secondary liver cancer
internal radiation therapy for liver cancer
irinotecan hepatoblastoma
is hepatoma benign or malignant
is liver cancer genetic
is secondary liver cancer terminal
is sorafenib considered chemotherapy
lenvatinib
lenvima liver cancer
lesions on lungs and liver
life expectancy hepatocellular carcinoma
liver cancer
liver cancer 20 year-old
Liver cancer causes
liver cancer centers of america
liver cancer ct scan images
liver cancer cure stories
liver cancer diagnosis stories
liver cancer easl
Liver cancer HCC
liver cancer immunotherapy results
Liver Cancer Impact Factor
liver cancer in children
liver cancer in your 20s
Liver Cancer journal
liver cancer on ct scan
liver cancer physical exam
liver cancer radiation beads
Liver cancer risk factor
liver cancer specialist near me
liver cancer spread to bones life expectancy
Liver cancer stage
liver cancer symptoms
liver cancer symptoms stage 4
Liver cancer treatment
liver cancer treatment cost
liver cancer treatment options
liver cancer treatment success rate
liver cancer treatment tablets
Liver cirrhosis
liver metastases surgery
liver nodule guideline
liver operation cancer
liver resection for cancer
liver surgery to remove tumor
liver tumor
Liver tumor ICD-10
lumps in liver
Lung cancer
management of advanced hcc
metastatic hepatocellular carcinoma prognosis
mgccc foundation scholarship
moffitt cancer center liver cancer
mycommnet housatonic
nanoknife liver cancer
natural cure for liver cancer stage 4
natural food remedies for liver cancer
Nejm hepatocellular carcinoma review
neuroblastoma
nevo chemotherapy
new liver cancer drugs
new liver cancer treatment
new treatment for hcc
nexavar (sorafenib tosylate)
nursing management of liver cancer
o sorafenib
operation of liver cancer
pediatric liver tumors
plural of cervix
pretext hepatoblastoma
pretext staging of hepatoblastoma
Primary HCC
prognosis of hcc
radiation for liver cancer
radiation pellets for liver cancer
radiation therapy for liver cancer
rate my professor hcc
refractory hepatoblastoma
regorafenib nci
renal cell carcinoma chemotherapy regimens
RFA
secondary liver cancer from breast
secondary liver cancer life expectancy
secondary liver cancer prognosis
sensitivity of afp for hcc
signs of hepatoblastoma relapse
siopel 3 protocol
siopel 5
sorafenib
sorafenib dose
sorafenib hcc
sorafenib side effects
stage 1 liver cancer symptoms
stage 1 liver cancer symptoms
stage 4 liver cancer treatment
stage 4 liver cancer what to expect
surgical management of liver cancer
systemic chemotherapy for hcc
systemic therapy hcc
TACE
tace medical abbreviation
top liver cancer surgeons
transarterial chemoembolization
treatment of early stage hcc
treatment protocols for hepatocellular carcinoma
unresectable hcc
unresectable hcc treatment
webadvisor hcc
what causes hepatoblastoma
what is advanced hepatocellular carcinoma
what is liver cancer
wilms tumor
Hepatocellular Carcinoma Chemotherapy
Hepatocellular Carcinoma Treatment
Hepatocellular Carcinoma Therapy
Hepatoma Chemotherapy
Hepatoma Treatment
Hepatoma Therapy
Liver Cancer Chemotherapy
Liver Cancer Treatment
Liver Cancer Therapy
HCC Chemotherapy
HCC Treatment
HCC Therapy